Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study

BACKGROUND: Inhaled corticosteroid/long-acting β(2)-agonist combinations (ICS/LABA) have emerged as first line therapies for chronic obstructive pulmonary disease (COPD) patients with exacerbation history. No randomized clinical trial has compared exacerbation rates among COPD patients receiving bud...

Full description

Saved in:
Bibliographic Details
Published in:Respir Res
Main Authors: Kern, David M, Davis, Jill, Williams, Setareh A, Tunceli, Ozgur, Wu, Bingcao, Hollis, Sally, Strange, Charlie, Trudo, Frank
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409772/
https://ncbi.nlm.nih.gov/pubmed/25899176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0210-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items